AMRX - Long Term Double Bottom

NYSE:AMRX   Amneal Pharmaceuticals, Inc
AMRX has hit a long term low point that has been seen to be a strong rejection point for the bulls
Price will likely double bottom and return upwards, as it did in the first situation where we see an inverse H&S


The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.